Literature DB >> 18717872

Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review.

Maria Ganeva1, Tanya Gancheva, Roumiana Lazarova, Jeni Troeva, Ivan Baldaranov, Ivan Vassilev, Evgenya Hristakieva, Valentina Tzaneva.   

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe drug reaction, most commonly to aromatic anticonvulsants with a delayed onset, variable clinical presentation and protracted course. The exact incidence of DRESS syndrome is not known because of the variability in clinical presentation, lack of strict diagnostic criteria and universally accepted nomenclature. We report four cases of DRESS syndrome associated with the use of carbamazepine. The clinical manifestation was similar: a maculopapular eruption progressing to exfoliative erythroderma, fever, and lymphadenopathy. Leukocytosis, atypical lymphocytes and liver injury (in 2 patients) were also observed. Assessment of causality using the Naranjo algorithm established a "probable" relationship with carbamazepine in three of the cases and a "possible" relationship in one case. Detection of DRESS syndrome is dependent on the exclusion of a variety of diseases with similar manifestations and may be delayed in time. DRESS syndrome is a potentially life-threatening multisystem adverse drug reaction, and accidental reexposure or drug provocation tests must be avoided.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18717872     DOI: 10.1111/j.1365-4632.2008.03637.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  14 in total

Review 1.  [Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a review].

Authors:  S Ständer; D Metze; T Luger; T Schwarz
Journal:  Hautarzt       Date:  2013-08       Impact factor: 0.751

Review 2.  Drug reactions with eosinophilia and systemic symptoms.

Authors:  B Scrace; A Fityan; C Bigham
Journal:  BJA Educ       Date:  2020-01-08

3.  PharmGKB summary: carbamazepine pathway.

Authors:  Caroline F Thorn; Susan G Leckband; John Kelsoe; J Steven Leeder; Daniel J Müller; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-12       Impact factor: 2.089

4.  Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin.

Authors:  Muhammad Riaz; Bruce D Ragsdale; Zia Ur Rahman; Gaurav Nigam
Journal:  BMJ Case Rep       Date:  2017-08-22

5.  Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7).

Authors:  Nehal Draz; Sumona Datta; Daniel P Webster; Ian Cropley
Journal:  BMJ Case Rep       Date:  2013-07-31

6.  Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.

Authors:  Yogita Ghodke Puranik; Angela K Birnbaum; Susan E Marino; Ghada Ahmed; James C Cloyd; Rory P Remmel; Ilo E Leppik; Jatinder K Lamba
Journal:  Pharmacogenomics       Date:  2013-01       Impact factor: 2.533

Review 7.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

8.  Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome.

Authors:  Yun-Jin Jeung; Jin-Young Lee; Mi-Jung Oh; Dong-Chull Choi; Byung-Jae Lee
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

9.  A case of DRESS syndrome associated with carbamazepine treatment.

Authors:  Adem Dursun; Ayşe Kaçar Bayram; Nazan Ülgen Tekerek; Başak Nur Akyıldız; Hüseyin Per
Journal:  Turk Pediatri Ars       Date:  2018-03-01

10.  Nitrofurantoin: cause of DRESS syndrome.

Authors:  Rodrigo Nazário Leão; Paulo Barreto; Ricardo R Leão; José Vaz Ribeiro
Journal:  BMJ Case Rep       Date:  2013-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.